ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., that it will be relying on CSA Coordinated Blanket Order 51-913 for an exemption from the requirements to send proxy-related materials for its upcoming annual general meeting (the “Meeting”) to be held on January 30, 2025, at 11:00 a.m. (Montréal time) (the “Proxy-Related Materials”), due to the current delays and suspension of mail service in Canada as a result of the nationwide strike of the Canadian Union of Postal Workers that commenced on November 15, 2024 (the “Postal Strike”).

Access to Documents

The Proxy-Related Materials are available under the Company’s profile on SEDAR+ at www.sedarplus.ca or on Cannara’s website at www.cannara.ca/investors.

Date and Time of the Meeting

The Meeting will be held a virtual-only format, which will be conducted via live audio webcast and teleconference accessible via the following link:

https://cannarabiotechquebecinc.my.webex.com/cannarabiotechquebecinc.my/j.php?MTID=m70400f296058ebb021572737a5824d6a

To join the meeting via teleconference, please dial 1-438-797-4001 (Canada) or 1-650-479-3208 (US) and use meeting code 2636 952 9781 and passcode LOVE2025 (56832025 when dialing from a phone or video system). Shareholders accessing the Meeting via teleconference will not be able to vote or speak at the Meeting. To vote or speak at the Meeting, shareholders will need to join the webcast and utilize the chat function during the Meeting. A moderator will be present to allow shareholders to vote or speak at the Meeting at the appropriate time.

Meeting Matters

In addition to receiving the Corporation’s consolidated financial statements for the fiscal year ended August 31, 2024, and the related auditor’s report, shareholders will be invited to vote on the following items at the meeting:

  1. to determine the number of directors and to elect the directors to serve until the Company’s next annual general meeting;
  2. to appoint MNP LLP as auditors of the Company for the ensuing year and to authorize the directors of the Company to fix the remuneration to be paid to the auditors for the ensuing year;
  3. to consider and, if thought fit, to pass an ordinary resolution to approve the Company’s stock option plan, amended, the whole as described in the accompanying management information circular;
  4. to consider and, if thought fit, to pass an ordinary resolution to approve the Company’s restricted share unit compensation plan, the whole as described in the accompanying management information circular;
  5. to transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.

CSA Coordinated Blanket Order 51-913

Recognizing that Postal Strike may impact a reporting issuer’s ability to deliver proxy-related materials to all shareholders, the Canadian Securities Administrators (CSA) published on December 4, 2024, Coordinated Blanket Order 51-931 Temporary Exemption from requirements in National Instrument 51-102 Continuous Disclosure Requirements and National Instrument 54-101 Communication with Beneficial Owners of Securities of a Reporting Issuer to send certain proxy-related materials during a postal strike (“Blanket Order 51-931”), providing temporary relief from the requirement to deliver proxy-related materials for annual meetings.

The conditions in Blanket Order 51-931 include a requirement that each of the matters at the Meeting would be considered an “annual matter”. Cannara confirms that it has complied with all conditions of this exemption.

Assistance

Shareholders of the Company are encouraged to access the Proxy-Related Materials directly through the above-mentioned websites, and registered shareholders and non-objecting beneficial shareholders may contact the Company’s transfer agent, Computershare Investor Services Inc. by calling toll free, within North America - 1-866-962-0498 or direct, from outside of North America - (514) 982-8716 to request copies of the Proxy-Related Materials or 1-800-564-6253 or direct, from outside of North America - 514-982-7555 to request voting control numbers for voting online at www.investorvote.com. Objecting beneficial shareholders should contact their broker to request their voting instruction forms, voting control numbers and instructions for voting.

In the event that the Postal Strike ends prior to the Meeting, the Company will mail the Proxy-Related Materials in the normal course, but there can be no assurance that the Proxy-Related Materials will be received by the shareholders prior to the Meeting.

ABOUT CANNARA

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.

CONTACT

Nicholas Sosiak, CPA, CA
Chief Financial Officer
nick@cannara.ca   
Zohar Krivorot 
President & Chief Executive Officer 
zohar@cannara.ca 


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.